| Income Statement for Idenix Pharmaceuticals Inc. (IDIX) | | | | | | | Income | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Operating Revenue | 68,028 | 67,377 | 64,718 | 95,389 | 29,570 | | Adjustments to Revenue | - | - | - | - | - | | Cost of Revenue | 6,954 | 3,401 | 2,066 | 1,304 | 632 | | Gross Operating Profit | 74,982 | 70,778 | 66,784 | 96,693 | 30,202 | | | Selling/General/Admin Expense | (63,348) | (56,954) | (33,657) | (23,603) | (20,193) | | Research & Development | (85,839) | (96,080) | (86,590) | (79,979) | (51,477) | | EBITDA | (74,205) | (82,256) | (53,463) | (6,889) | (41,468) | | Depreciation & Amortization | (8,955) | (3,463) | (2,066) | (1,304) | (632) | | EBIT | (83,160) | (85,719) | (55,529) | (8,193) | (42,100) | | Interest Income | - | - | - | - | 430 | | Other Income, Net | 6,387 | 9,487 | 4,038 | 1,383 | (26) | | Total Income Avail For Interest Expense | (82,017) | (76,232) | (51,491) | (6,810) | (41,696) | | Interest Expense | - | - | - | - | - | | Pre-Tax Income | (82,017) | (76,232) | (51,491) | (6,810) | (41,696) | | Income Taxes | (498) | 1,145 | 714 | 566 | (184) | | Minority Interest | - | - | - | - | - | | Net Income from Continuing Operations | (82,515) | (75,087) | (50,777) | (6,244) | (41,880) | | Net Income from Discontinued Operations | - | - | - | - | - | | Net Income from Total Operations | (82,515) | (75,087) | (50,777) | (6,244) | (41,880) | | | Normalized Income | (73,771) | (75,087) | (50,777) | (6,244) | (41,880) | | Extraordinary Income | - | - | - | - | - | | Special Income/Charges | (8,744) | - | - | - | - | | Income from Cum. Effect of Acct Change | - | - | - | - | - | | Income from Tax Loss Carryforward | - | - | - | - | - | | Other Gains | - | - | - | - | - | | Total Net Income | (82,515) | (75,087) | (50,777) | (6,244) | (41,880) | | | Results | in Dollars (Preferred Dividends in Thousands) | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Dividends Paid Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Preferred Dividends | - | - | - | - | 29,074 | | | Basic EPS from Continuing Operations | -1.47 | -1.34 | -1.03 | -0.15 | -2.70 | | Basic EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Basic EPS from Total Operations | -1.47 | -1.34 | -1.03 | -0.15 | -2.70 | | | Diluted EPS from Continuing Operations | -1.47 | -1.34 | -1.03 | -0.15 | -2.70 | | Diluted EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Diluted EPS from Total Operations | -1.47 | -1.34 | -1.03 | -0.15 | -2.70 | | | |
